This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
|Articles|January 2, 2014
- Pharmaceutical Technology-01-02-2014
- Volume 38
- Issue 1
ALpHA G Capsule Filter for Single-Use Systems
Author(s)Melanie Sena
ALpHA G Capsule Filter for Single-Use Systems
The ALpHA G is an absolute rated depth type prefilter, which has been optimized for compatibility with a gamma irradiation cycle commonly used to sterilize single-use systems. ALpHA G features a tapered pore structure, which provides high flow rates and delivers increased dirt holding capacity. ALpHA G capsule filters are available in retention ratings from 0.6 μm to 20 μm. The filter can be specified in a wide range of capsule configurations to provide seamless scalability from laboratory work and process development through production. For applications requiring multistage filtration and larger surface areas than can be accommodated by a single filter, the ALpHA G media can be specified in the UltraSnap filter assembly. The UltraSnap assembly can be delivered as a single presterilized unit with one inlet and one outlet for maximum convenience and plug and play functionality.
Articles in this issue
over 12 years ago
UK Biotech Gains Momentumalmost 13 years ago
Drugs, At What Cost?almost 13 years ago
CS Inspection Machine Improves Efficiencyalmost 13 years ago
Ribbon Blender Model 42N-270 Increases Performancealmost 13 years ago
Innovation and Market Growth in Brazilalmost 13 years ago
R&D in Transitionalmost 13 years ago
Battling Off-Weight Tabletsalmost 13 years ago
Metrics Sought to Ensure Drug Qualityalmost 13 years ago
Gericke N200 Nibbler Provides Size Reductionalmost 13 years ago
Qualifying Personnel to Visually Inspect Cleaned EquipmentRelated to this article
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Richard Jaenisch weighs how FDA's new NAM rule could reshape preclinical testing and what CMC teams should do now, on Manufacturing Intelligence.